Raising $20.8 million in 2025, a firm linking life sciences data with AI via secure networks aimed to boost drug discovery through global collaborations.
Wenham Carter’s targeted strategic introduction placed a Vice President of Life Sciences with biopharma expertise to build partnerships.
The Vice President of Life Sciences has strengthened biotech ties, advancing drug discovery. Wenham Carter aids team expansion.





